In summary, our research results suggest that FMN can inhibit macrophage polarization toward the M1 phenotype (iNOS), suppress the release of proinflammatory factors, such as IL-1β, and promote M2-type polarization, thereby reducing inflammation and alleviating atherosclerosis. Here, IL1B is linked to atherosclerosis.